MarketInOut Stock Screener Log In | Sign Up
 

NIOX Group Plc

LSE • Healthcare • Medical Devices • Quote as of 10/23/2026 16:35
NIOX Group Plc stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeLSE
Market Capitalization277.77 mln
Float308 mln
Earnings Date03/23/2027

EPS

2.00
Stretched

P / E

34.50
Overvalued

Piotroski F-Score

8 / 9
Very strong

Beneish M-Score

-3.02
Reliable

1-Year Forecast

82.40
Attractive

Relative Strength

78 / 100
Strongly outperforming

Business Description

NIOX Group Plc, based in Oxford, United Kingdom, develops and sells medical tools that help doctors diagnose and manage respiratory conditions like asthma and COPD. Its main product, NIOX VERO, is a compact handheld device that measures a specific marker in a patient's breath to assess airway inflammation quickly and without any invasive procedures. Originally founded in 2006 under the name Circassia Group Plc, the company rebranded to its current name in September 2022.

Key Fundamentals

EPS2.00
P/E34.50
ROE10.28
RPS0.11
ROIC12.28
ROA9.53
Interest Cover52.00
EBITDA, mln15.80
EV / EBITDA17.30
EV / EBIT23.77
Revenue, mln47.50
EV / Revenue5.75

Quote Details

Last 68.80
Change 1 (1.47%)
Open 66.00
Volume 104,058
Turnover 7,159,190
Average Volume 1,113,706

Financial Ratios

Pre-Tax Profit Margin24
Leverage Ratio1.11
Current Ratio4.60
Price / Book4.39
Price / Tangible Book6.90
Price / Cash Flow21.78
Price / Free Cash Flow23.79
Debt / Equity0.01
Price / Sales6.22

Financial Strength

Altman Z-Score22.29
Piotroski F-Score 8 / 9
Beneish M-Score-3.02
Price to Intrinsic Value4.60
Price to Graham Number3.63
1-Year Target Price82.40

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 1.18% 84 / 100   
1 Month 1.47% 78 / 100   
2 Months 16.22% 91 / 100   
6 Months 3.83% 56 / 100   
1 Year 1.45% 38 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog